Seres Therapeutics, Inc. (MCRB) News
Follow Seres Therapeutics, Inc. (MCRB) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 10 public stories across 6 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Seres Therapeutics Reports Quarterly Results for Period Ended September 30
EQUITY | Nov 04, 2026, 01:42 PM UTC
M
Seres Therapeutics Q3 Earnings Snapshot
Seres Therapeutics (MCRB) reported results for the third quarter.
EQUITY | Nov 04, 2026, 12:27 PM UTC
M
Seres Therapeutics Reports Third-Quarter 2026 Financial Results, Plans SER-155 Development
Seres Therapeutics reported third-quarter 2026 financial results and announced plans to advance development of SER-155 to prevent immune checkpoint inhibitor-related enterocolitis.
EQUITY | Nov 04, 2026, 12:12 PM UTC
L
Seres Therapeutics Says SER-155 Cut Infection Risk 77% in Phase 1b Trial
The Phase 1b trial reported a 77% reduction in bloodstream infection risk.
EQUITY | Nov 03, 2026, 12:10 PM UTC
L
Seres Therapeutics grants inducement equity under Nasdaq Rule 5635(c)(4)
Seres Therapeutics said its board Compensation and Talent Committee granted inducement equity on September 4, 2026, under Nasdaq Listing Rule 5635(c)(4).
EQUITY | Sep 08, 2026, 10:07 PM UTC
L
MCRB reports inducement grants under Nasdaq Rule 5635(c)(4)
Seres Therapeutics (MCRB) reported inducement grants under Nasdaq Listing Rule 5635(c)(4).
EQUITY | Sep 08, 2026, 10:00 PM UTC
L
Seres Therapeutics management to attend H.C. Wainwright conference in New York
Seres Therapeutics said management will attend the H.C. Wainwright 28th Annual Global Investment Conference in New York, NY and will present at the event.
EQUITY | Sep 01, 2026, 11:07 AM UTC
L
MCRB - Seres Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference
MCRB - Seres Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference
EQUITY | Sep 01, 2026, 11:00 AM UTC
L
MCRB - Seres Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates, Including Further Action to Reduce On
MCRB - Seres Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates, Including Further Action to Reduce Ongoing Facilities Costs
EARNINGS | Aug 05, 2026, 11:01 AM UTC
H
Morning Movers: Beazer jumps after revised Dream Finders acquisition proposal
Stock futures are lower ahead of the opening bell as renewed fighting between the U.S. and Iran sends oil prices sharply higher. President Donald Trump said a ceasefire aimed at ending the conflict was "over," fueling co
COMMODITIES | Jul 08, 2026, 01:06 PM UTC